Investigation of new target of tolerance of molecular target drug for non small cell lung cancer

• Project/Area Number: 25860654
• Research Category: Grant-in-Aid for Young Scientists (B)
• Allocation Type: Multi-year Fund
• Research Field: Respiratory organ internal medicine
• Research Institution: Saitama Medical University
• Principal Investigator: ISHIKAWA Rinako 埼玉医科大学, 医学部, 助教 (10633844)
• Project Period (FY): 2013-04-01 – 2015-03-31
• Project Status: Completed (Fiscal Year 2014)
• Budget Amount: ¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000); Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000); Fiscal Year 2013: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
• Keywords: 非小細胞肺癌 / 分子標的治療 / 耐性遺伝子 / 肺癌 / 分子生物学 / 癌関連遺伝子

Outline of Final Research Achievements

Patients　of Non-small cell lung cancer(NSCLC) are increasing. NSCLC is one of major cause of death. New strategy for NSCLC is needed. Our purpose of this study is finding new target of tolerance of molecular target drug. In our study, we find one candidate gene.